66
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Survival outcomes of radical prostatectomy and external beam radiotherapy in clinically localized high-risk prostate cancer: a population-based, propensity score matched study

, , , , , , , , & show all
Pages 1061-1067 | Published online: 08 May 2018

References

  • SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
  • MakarovDVTrockBJHumphreysEBUpdated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005Urology20076961095110117572194
  • D’AmicoAVWhittingtonRMalkowiczSBBiochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancerJAMA1998280119699749749478
  • MohlerJLArmstrongAJBahnsonRRProstate cancer, version 1.2016 featured updates to the NCCN GuidelinesJ Natl Compr Canc Netw2016141193026733552
  • HamdyFCDonovanJLLaneJA10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancerN Engl J Med2016375151415142427626136
  • SooriakumaranPNybergTAkreOComparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomesBMJ2014348g150224574496
  • YamamotoSKawakamiSYoneseJLong-term oncological outcome in men with T3 prostate cancer: radical prostatectomy versus external-beam radiation therapy at a single institutionInt J Clin Oncol20141961085109124346487
  • SaitoTKitamuraYKomatsubaraSMatsumotoYSugitaTHaraNOutcomes of locally advanced prostate cancer: a single institution study of 209 patients in JapanAsian J Androl20068555556116847528
  • ThariatJHannoun-LeviJMMyintASVuongTGerardJPPast, present, and future of radiotherapy for the benefit of patientsNat Rev Clin Oncol2013101526023183635
  • Database S [webpage on the Internet]PSA Values and SEER Data2017 Available from: https://seer.cancer.gov/data/psa-values.htmlAccessed April 14, 2017
  • D’AgostinoRBPropensity score methods for bias reduction in the comparison of a treatment to a non-randomized control groupStat Med19981719226522819802183
  • PetrelliFVavassoriICoinuABorgonovoKSartiEBarniSRadical prostatectomy or radiotherapy in high-risk prostate cancer: a systematic review and metaanalysisClin Genitourin Cancer201412421522424589471
  • WallisCJDSaskinRChooRSurgery versus radiotherapy for clinically-localized prostate cancer: a systematic review and meta-analysisEur Urol2016701213026700655
  • DonovanJLHamdyFCLaneJAPatient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancerN Engl J Med2016375151425143727626365
  • PeetersSTHeemsbergenWDKoperPCDose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 GyJ Clin Oncol200624131990199616648499
  • ZietmanALDeSilvioMLSlaterJDComparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trialJAMA2005294101233123916160131
  • DearnaleyDPJovicGSyndikusIEscalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trialLancet Oncol201415446447324581940
  • KalbasiALiJBermanADose-escalated irradiation and overall survival in men with nonmetastatic prostate cancerJAMA Oncol20151789790626181727
  • Van der KwastTHBollaMVan PoppelHEORTC 22911. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911J Clin Oncol200725274178418617878474
  • ThompsonIMTangenCMParadeloJAdjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trialJ Urol2009181395696219167731
  • WiegelTBottkeDSteinerUPhase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95J Clin Oncol200927182924293019433689